[1] YANG Y, ZHAO X, ZHU Z, et al. Vascular dementia: A microglia’s perspective. Ageing Res Rev. 2022;81:101734.
[2] BIR SC, KHAN MW, JAVALKAR V, et al. Emerging Concepts in Vascular Dementia: A Review. J Stroke Cerebrovasc Dis. 2021;30(8):105864.
[3] LECORDIER S, MANRIQUE-CASTANO D, EL MOGHRABI Y, et al. Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors. Front Aging Neurosci. 2021:13:727590.
[4] ROMAY MC, TORO C, IRUELA-ARISPE ML. Emerging molecular mechanisms of vascular dementia. Curr Opin Hematol. 2019;26(3): 199-206.
[5] VITALAKUMAR D, SHARMA A, FLORA SJS. Ferroptosis: A potential therapeutic target for neurodegenerative diseases. J Biochem Mol Toxicol. 2021;35(8):e22830.
[6] FU P, CHEN Y, WU M, et al. Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. Exp Neurol. 2023;370:114538.
[7] THOMAS GEC, LEYLAND LA, SCHRAG AE, et al. Brain iron deposition is linked with cognitive severity in Parkinson’s disease.J Neurol Neurosurg Psychiatry. 2020;91(4):418-425.
[8] JAKARIA M, BELAIDI AA, BUSH AI, et al. Ferroptosis as a mechanism of neurodegeneration in Alzheimer’s disease. J Neurochem. 2021; 159(5):804-825.
[9] JI Y, ZHENG K, LI S, et al. Insight into the potential role of ferroptosis in neurodegenerative diseases. Front Cell Neurosci. 2022;16:1005182.
[10] VENKAT P, CHOPP M, ZACHAREK A, et al. Sildenafil treatment of vascular dementia in aged rats. Neurochem Int. 2019;127:103-112.
[11] KUANG H, ZHOU ZF, ZHU YG, et al. Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective. Aging Dis. 2021;12(1):308-326.
[12] KERINS MJ, OOI A. The Roles of NRF2 in Modulating Cellular Iron Homeostasis. Antioxid Redox Signal. 2018;29(17):1756-1773.
[13] YANG T, ZHANG F. Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia. Arterioscler Thromb Vasc Biol. 2021;41(1):97-116.
[14] NISHIZAWA H, YAMANAKA M, IGARASHI K. Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal.FEBS J. 2023;290(7):1688-1704.
[15] MAO L, YANG T, LI X, et al. Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway. J Cereb Blood Flow Metab. 2019;39(2):352-366.
[16] HUANG Q, JI D, TIAN X, et al. Berberine inhibits erastin-induced ferroptosis of mouse hippocampal neuronal cells possibly by activating the Nrf2-HO-1/GPX4 pathway. Nan Fang Yi Ke Da Xue Xue Bao. 2022; 42(6):937-943.
[17] 王建婷, 谭子虎, 周剑杰, 等. 基于Cx43/Glu/AMPAR通路探讨加减薯蓣丸对血管性痴呆大鼠海马髓鞘损伤的影响[J]. 中国实验方剂学杂志,2023,29(7):38-46.
[18] 孙晓丽,张锴镔,郭淑贞,等.龙生蛭胶囊对血管痴呆大鼠认知功能的影响及作用机制[J].中国实验方剂学杂志,2022,28(9):72-79.
[19] YANG X, CHEN C, WANG A, et al. Imaging, Genetic, and Pathological Features of Vascular Dementia. Eur Neurol. 2023;86(4):277-284.
[20] YAN N, ZHANG J. Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease. Front Neurosci. 2020;13:1443.
[21] SUN Y, CHEN P, ZHAI B, et al. The emerging role of ferroptosis in inflammation.Biomed Pharmacother. 2020;127:110108.
[22] LI Y, ZHOU Y, ZHANG D, et al. Hypobaric hypoxia regulates iron metabolism in rats.J Cell Biochem. 2019;120(8):14076-14087.
[23] DIXON SJ, LEMBERG KM, LAMPRECHT MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060-1072.
[24] EMERIT J, BEAUMONT C, TRIVIN F. Iron metabolism, free radicals, and oxidative injury.Biomed Pharmacother. 2001;55(6):333-339.
[25] FENG L, SUN J, XIA L, et al. Ferroptosis mechanism and Alzheimer’s disease. Neural Regen Res. 2024;19(8):1741-1750.
[26] PLASCENCIA-VILLA G, PERRY G. Preventive and Therapeutic Strategies in Alzheimer’s Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.Antioxid Redox Signal. 2021;34(8):591-610.
[27] KOBAYASHI M, YAMAMOTO M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 2005;7(3-4):385-394.
[28] ZHANG X, YU Y, LEI H, et al. The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases. Cardiol Res Pract. 2020:2020:5695723.
[29] DANG R, WANG M, LI X, et al. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway. J Neuroinflammation. 2022;19(1):41.
[30] YAN N, ZHANG JJ. The Emerging Roles of Ferroptosis in Vascular Cognitive Impairment. Front Neurosci. 2019;13:811.
[31] 向岁, 石和元, 谭爱华, 等. 基于“脑肠轴”学说探讨血管性痴呆的中医脑肠同治思路[J]. 时珍国医国药,2021,32(9):2231-2233.
[32] 张寒玉, 程红亮, 胡培佳, 等. 基于“元阳虚衰、痰瘀阻窍”理论探讨血管性痴呆辨经论治[J]. 中医药临床杂志,2022,34(11):2000-2003.
[33] 朱健敏, 林龙, 陈炜, 等. TLR4/NF-κB信号通路调控血管性痴呆小胶质细胞极化以及中医治疗的研究进展[J]. 中华中医药学刊, 41(4):109-113.
|